Impact of concomitant proton pump inhibitors in patients treated for advanced or metastatic NSCLC: a target trial emulation protocol
Florent Le Borgne(Université de Tours), D. Pérol, L. Bosquet(UniCancer Group), A. de Montfort, B. Guégo, F. Bocquet, M. Robain, Catherine Guérin‐Charbonnel(Institut de Cancérologie de l'Ouest), J.-L. Raoul, E. Martin(Institut de Cancérologie de l'Ouest)
Cited by 0
Related Papers
G-computation, propensity score-based methods, and targeted maximum likelihood estimator for causal inference with different covariates sets: a comparative simulation study
|Scientific Reports|2020|126
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
|Nature Communications|2020|121
Antigens of the basement membrane and the peritumoral stroma in human colonic adenocarcinomas: An immunofluorescence study
|International Journal of Cancer|1982|99
Observer Variation in Assessment of Liver Biopsies of Alcoholic Patients
|Alcoholism Clinical and Experimental Research|1988|95